Q3 Revenue Falls 24.5% to $45.2M; Q4 Guidance Points to Further Decline
BODI is trading near its 52-week low of $4.01 (12% above the low) on elevated volume (2.4× avg).
Summary
Revenue dropped 24.5% to $45.2 million from $59.9 million a year ago, with digital subscriptions down 23.3% to 0.69 million and nutrition subscriptions down 14.3%. Management said net income and adjusted EBITDA beat the high end of guidance, but both shrank year over year: net income was $3.3 million versus $3.6 million, and adjusted EBITDA fell 32.6% to $6.4 million. The bigger problem is cash: nine-month operating cash flow swung to negative $10.1 million from positive $16.8 million, and free cash flow was negative $12.1 million versus positive $13.1 million. Q4 guidance calls for revenue of $38 million to $42 million, which at the midpoint implies another roughly 25% decline, with adjusted EBITDA of $6 million to $9 million. Cash stood at $27.5 million against $22.9 million of debt, leaving a thin net cash cushion for a company burning cash.
At the time of this announcement, BODI was trading at $4.51 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $32.9M. The 52-week trading range was $4.01 to $16.87. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.